Profile: Accumetrics is committed to advancing medical understanding of platelets and enhancing quality of care for patients who are at risk of cardiovascular disease by providing industry-leading diagnostic tests to assess response to every major type of antiplatelet therapy, including aspirin, P2Y12 inhibitors (Plavix® and Effient®) and GP IIb/IIIa inhibitors (e.g. ReoPro® and Integrilin®). Accumetrics’ family of VerifyNow® tests provides physicians with rapid, easy and valuable tools to help make informed treatment decisions.
Accumetrics is committed to advancing medical understanding of platelets and enhancing quality of care for patients who are at risk of cardiovascular disease by providing industry-leading diagnostic tests to assess response to every major type of antiplatelet therapy, including aspirin, P2Y12 inhibitors (Plavix® and Effient®) and GP IIb/IIIa inhibitors (e.g. ReoPro® and Integrilin®). Accumetrics’ family of VerifyNow® tests provides physicians with rapid, easy and valuable tools to help make informed treatment decisions.
Brands: VerifyNow®
Categories: Medical Devices Instrumentation Interventional - Other Percutaneous Endovascular and Cardiac Devices Medical Equipment Clinical Laboratory and Testing Services Research Clinical Trials Market Research
Copyright 2013-14 © a2z, Inc. All rights reserved.
© 2011 American College of Cardiology Foundation | Contact Us | ACC.12